SUMMA HEALTH SYSTEM
🇺🇸United States
Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer
PSC genomic classifier predicts prognosis and benefits of LT-ADT in high-risk PCa, with basal subtype showing worse outcomes and greater benefit from LT-ADT, suggesting personalized ADT recommendations.
© Copyright 2025. All Rights Reserved by MedPath